Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cholesterol side-chain cleavage enzyme (CYP11A1), also known as P450scc, is a mitochondrial cytochrome P450 monooxygenase that catalyzes the conversion of cholesterol to pregnenolone. This is the first and rate-limiting step in steroidogenesis, leading to the biosynthesis of all steroid hormones. Deficiency or mutations in CYP11A1 cause congenital lipoid adrenal hyperplasia, characterized by adrenal insufficiency and impaired sexual development.
Inhibition of cholesterol conversion to pregnenolone
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholesterol Side Chain Cleavage Enzyme (CYP11A1).